Back to WASATCH ADVISORS LP WASATCH ADVISORS LP

ESPRESPR
Showing 8 of 30 quarters

Position history for WASATCH ADVISORS LPWASATCH ADVISORS LP's holdings in ESPERION THERAPEUTICS INC NE

WASATCH ADVISORS LP holds 1.9M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $6.1M as of 2026-Q2. The position was decreased (-87.8% shares). ESPR represents 0.0% of WASATCH ADVISORS LP's portfolio.

Current Value

$6.1M

Current Shares

1.9M

Total Value Change

-$32.4M

Total Shares Change

-21.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.9M
-87.8%
$6.1M0.0%$3.12
0
2026-Q1
Increased
15.8M
+66.9%
$43.2M0.3%$2.91
51
2025-Q4
Increased
9.4M
+33.8%
$34.9M0.2%$3.69
45
2025-Q3
Decreased
7.1M
-31.7%
$18.7M0.1%$2.64
0
2025-Q2
Decreased
10.3M
-5.4%
$10.2M0.1%$0.99
0
2025-Q1
Decreased
10.9M
-55.4%
$15.7M0.1%$1.50
0
2024-Q4
Increased
24.5M
+4.9%
$53.9M0.3%$2.15
37
2024-Q3
Increased
23.3M
+38.5%
$38.5M0.2%$1.68
46

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used